Figure 3.
Wnt7a reduces phagocytic ability of monocyte‐derived macrophages (MDMs). (a) Phagocytic potential of human M‐MDM with or without Wnt1 or Wnt7a treatment was assessed using immune fluorescence (a) of pHrodo® Red Staphylococcus aureus Bioparticles®, white arrows indicate non‐phagocytic cells (n = 3) and by flow cytometry (b) for PE (excitation 585 nm) MFI of experimental group in comparison with control MDMs (n = 3, *P < 0·05 for M‐MDM versus M‐MDM + Wnt7a).